Approaches for RAI therapy and RAI refractory (non-avid, RAI resistant) disease. 151

Поделиться
HTML-код
  • Опубликовано: 19 авг 2024
  • Approaches for RAI therapy and RAI refractory (non-avid, RAI resistant) disease. [Adv,H,PF,SR]
    Mabel Ryder, MD, Endocrinologist.
    Originally presented by @ThyCaInc at the 25th International Thyroid Cancer Survivors' Virtual Conference held in September of 2022.

Комментарии •

Следующие
Автовоспроизведение
Development of Decision Aid for Radioactive Iodine Therapy among Thyroid Cancer Patients 14554:21Development of Decision Aid for Radioactive Iodine Therapy among Thyroid Cancer Patients 145
Development of Decision Aid for Radioactive Iodine Therapy among Thyroid Cancer Patients 145ThyCa: Thyroid Cancer Survivors' Association, Inc.
Просмотров 337
Radioactive iodine (RAI) therapy for RAI-refractory disease: “redifferentiation” with Dr. Sherman34:22Radioactive iodine (RAI) therapy for RAI-refractory disease: “redifferentiation” with Dr. Sherman
Radioactive iodine (RAI) therapy for RAI-refractory disease: “redifferentiation” with Dr. ShermanThyCa: Thyroid Cancer Survivors' Association, Inc.
Просмотров 419
351 The importance of lifetime follow-up1:00:36351 The importance of lifetime follow-up
351 The importance of lifetime follow-upThyCa: Thyroid Cancer Survivors' Association, Inc.
Просмотров 357
212 Drugs in development for RAI-refractory differentiated thyroid cancer. New Molecular Targets57:15212 Drugs in development for RAI-refractory differentiated thyroid cancer. New Molecular Targets
212 Drugs in development for RAI-refractory differentiated thyroid cancer. New Molecular TargetsThyCa: Thyroid Cancer Survivors' Association, Inc.
Просмотров 289
Unusual Complications of WM Concerns & Best Practices1:02:54Unusual Complications of WM Concerns & Best Practices
Unusual Complications of WM Concerns & Best PracticesInternational Waldenstrom's Macroglobulinemia Foundation
Просмотров 3,9 тыс.
Preview of preliminary work done for next iteration of the ATA guidelines for differentiated TC. 3211:00:09Preview of preliminary work done for next iteration of the ATA guidelines for differentiated TC. 321
Preview of preliminary work done for next iteration of the ATA guidelines for differentiated TC. 321ThyCa: Thyroid Cancer Survivors' Association, Inc.
Просмотров 848
Thyroid Nodules - Causes, Symptoms and Treatments17:47Thyroid Nodules - Causes, Symptoms and Treatments
Thyroid Nodules - Causes, Symptoms and TreatmentsTalking With Docs
Просмотров 395 тыс.
Gynecologic Cancer Education: PARP Inhibitor Therapy24:56Gynecologic Cancer Education: PARP Inhibitor Therapy
Gynecologic Cancer Education: PARP Inhibitor TherapyMayo Clinic
Просмотров 4,5 тыс.
Meet the Masters World Congress on Thyroid Cancer 20171:01:04Meet the Masters World Congress on Thyroid Cancer 2017
Meet the Masters World Congress on Thyroid Cancer 2017World Congress on Thyroid Cancer
Просмотров 553
RAI and Nuclear Medicine in Thyroid Cancer.22:16RAI and Nuclear Medicine in Thyroid Cancer.
RAI and Nuclear Medicine in Thyroid Cancer.ThyCa: Thyroid Cancer Survivors' Association, Inc.
Просмотров 9 тыс.
Panel 1 Management of Thyroid Nodules World Congress on Thyroid Cancer 20171:23:35Panel 1 Management of Thyroid Nodules World Congress on Thyroid Cancer 2017
Panel 1 Management of Thyroid Nodules World Congress on Thyroid Cancer 2017World Congress on Thyroid Cancer
Просмотров 9 тыс.
Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer57:02Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer
Redifferentiation of Radioiodine Refractory Differentiated Thyroid CancerIcahn School of Medicine
Просмотров 728